US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist

8.880
-0.090-1.00%

Trading May 14 12:47 ET

598.71MMarket Cap-4933P/E (TTM)

Oric Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-46.34%-30.19M

-14.03%-85.69M

-58.33%-24.27M

-1.68%-19.65M

-18.95%-21.15M

9.20%-20.63M

-26.20%-75.14M

5.86%-15.33M

-59.12%-19.32M

-9.63%-17.78M

Net income from continuing operations

-4.45%-25.01M

-12.99%-100.7M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

-13.22%-89.12M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

Operating gains losses

----

-45.00%22K

--13K

--0

----

1,900.00%40K

----

Depreciation and amortization

3.16%261K

6.83%1.03M

6.48%263K

16.29%257K

4.86%259K

0.80%253K

7.69%966K

7.86%247K

1.84%221K

11.26%247K

Change In working capital

-2,726.05%-8.17M

1,200.67%4.9M

-27.09%1.98M

53.66%3.63M

40.54%-1.03M

108.19%311K

-110.93%-445K

4.21%2.72M

1.07%2.37M

-286.85%-1.73M

-Change in prepaid assets

-318.40%-2.41M

57.28%1.62M

-21.30%1.01M

-114.85%-277K

86.61%-211K

305.78%1.1M

-9.81%1.03M

867.42%1.28M

165.29%1.87M

-40.09%-1.58M

-Change in payables and accrued expense

-627.02%-5.76M

322.24%3.28M

-32.20%979K

682.20%3.91M

-418.99%-820K

75.71%-792K

-150.32%-1.48M

-41.75%1.44M

-69.46%500K

-107.70%-158K

Cash from discontinued investing activities

Operating cash flow

-46.34%-30.19M

-14.03%-85.69M

-58.33%-24.27M

-1.68%-19.65M

-18.95%-21.15M

9.20%-20.63M

-26.20%-75.14M

5.86%-15.33M

-59.12%-19.32M

-9.63%-17.78M

Investing cash flow

Cash flow from continuing investing activities

-584.18%-61.87M

60.27%-43.4M

-25.93%20.96M

-8,342.48%-57.83M

58.20%-19.31M

114.09%12.78M

-168.95%-109.25M

7,962.68%28.3M

-101.95%-685K

-156.10%-46.2M

Net PPE purchase and sale

29.68%-218K

59.14%-849K

80.14%-57K

80.80%-77K

39.28%-405K

57.12%-310K

-121.30%-2.08M

26.22%-287K

-72.10%-401K

-394.07%-667K

Net investment purchase and sale

-571.04%-61.65M

60.29%-42.55M

-26.47%21.02M

-20,235.92%-57.75M

58.48%-18.91M

114.55%13.09M

-167.24%-107.17M

3,763.11%28.59M

-100.80%-284K

-155.20%-45.54M

Cash from discontinued investing activities

Investing cash flow

-584.18%-61.87M

60.27%-43.4M

-25.93%20.96M

-8,342.48%-57.83M

58.20%-19.31M

114.09%12.78M

-168.95%-109.25M

7,962.68%28.3M

-101.95%-685K

-156.10%-46.2M

Financing cash flow

Cash flow from continuing financing activities

125.03M

239.58%85.66M

-98.17%453K

3,000.00%31K

20,423.86%85.17M

-48.66%25.23M

2,949.57%24.79M

-100.00%1K

247.69%415K

Net common stock issuance

--125M

240.00%85M

-99.10%226K

--0

--84.77M

--0

-50.00%25M

--25M

--0

----

Proceeds from stock option exercised by employees

--198K

41.83%885K

136.46%454K

3,000.00%31K

-3.61%400K

--0

-36.71%624K

-76.38%192K

-98.99%1K

615.52%415K

Net other financing activities

---168K

43.11%-227K

----

78.46%-399K

----

Cash from discontinued financing activities

Financing cash flow

--125.03M

239.58%85.66M

-98.17%453K

3,000.00%31K

20,423.86%85.17M

--0

-48.66%25.23M

2,949.57%24.79M

-100.00%1K

247.69%415K

Net cash flow

Beginning cash position

-64.53%23.88M

-70.28%67.31M

-9.53%26.73M

110.25%104.17M

-47.43%59.46M

-70.28%67.31M

188.70%226.47M

-87.77%29.54M

-70.87%49.55M

8.54%113.11M

Current changes in cash

520.08%32.98M

72.71%-43.43M

-107.56%-2.85M

-287.15%-77.45M

170.35%44.72M

93.08%-7.85M

-207.52%-159.17M

349.76%37.76M

-127.97%-20M

-196.50%-63.56M

End cash Position

-4.38%56.85M

-64.53%23.88M

-9.53%26.73M

110.25%104.17M

-47.43%59.46M

-70.28%67.31M

-87.77%29.54M

-70.87%49.55M

Free cash flow

-45.21%-30.4M

-12.06%-86.54M

-55.78%-24.33M

-0.01%-19.72M

-16.85%-21.55M

10.68%-20.94M

-27.68%-77.22M

6.34%-15.62M

-59.36%-19.72M

-12.81%-18.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-46.34%-30.19M	-14.03%-85.69M	-58.33%-24.27M	-1.68%-19.65M	-18.95%-21.15M	9.20%-20.63M	-26.20%-75.14M	5.86%-15.33M	-59.12%-19.32M	-9.63%-17.78M
Net income from continuing operations	-4.45%-25.01M	-12.99%-100.7M	-35.89%-28.33M	-2.61%-25.48M	-13.10%-22.94M	-3.39%-23.95M	-13.22%-89.12M	8.45%-20.85M	-34.75%-24.83M	3.44%-20.29M
Operating gains losses	----	-45.00%22K	--13K	--0	----	----	1,900.00%40K	----	----	----
Depreciation and amortization	3.16%261K	6.83%1.03M	6.48%263K	16.29%257K	4.86%259K	0.80%253K	7.69%966K	7.86%247K	1.84%221K	11.26%247K
Change In working capital	-2,726.05%-8.17M	1,200.67%4.9M	-27.09%1.98M	53.66%3.63M	40.54%-1.03M	108.19%311K	-110.93%-445K	4.21%2.72M	1.07%2.37M	-286.85%-1.73M
-Change in prepaid assets	-318.40%-2.41M	57.28%1.62M	-21.30%1.01M	-114.85%-277K	86.61%-211K	305.78%1.1M	-9.81%1.03M	867.42%1.28M	165.29%1.87M	-40.09%-1.58M
-Change in payables and accrued expense	-627.02%-5.76M	322.24%3.28M	-32.20%979K	682.20%3.91M	-418.99%-820K	75.71%-792K	-150.32%-1.48M	-41.75%1.44M	-69.46%500K	-107.70%-158K
Cash from discontinued investing activities
Operating cash flow	-46.34%-30.19M	-14.03%-85.69M	-58.33%-24.27M	-1.68%-19.65M	-18.95%-21.15M	9.20%-20.63M	-26.20%-75.14M	5.86%-15.33M	-59.12%-19.32M	-9.63%-17.78M
Investing cash flow
Cash flow from continuing investing activities	-584.18%-61.87M	60.27%-43.4M	-25.93%20.96M	-8,342.48%-57.83M	58.20%-19.31M	114.09%12.78M	-168.95%-109.25M	7,962.68%28.3M	-101.95%-685K	-156.10%-46.2M
Net PPE purchase and sale	29.68%-218K	59.14%-849K	80.14%-57K	80.80%-77K	39.28%-405K	57.12%-310K	-121.30%-2.08M	26.22%-287K	-72.10%-401K	-394.07%-667K
Net investment purchase and sale	-571.04%-61.65M	60.29%-42.55M	-26.47%21.02M	-20,235.92%-57.75M	58.48%-18.91M	114.55%13.09M	-167.24%-107.17M	3,763.11%28.59M	-100.80%-284K	-155.20%-45.54M
Cash from discontinued investing activities
Investing cash flow	-584.18%-61.87M	60.27%-43.4M	-25.93%20.96M	-8,342.48%-57.83M	58.20%-19.31M	114.09%12.78M	-168.95%-109.25M	7,962.68%28.3M	-101.95%-685K	-156.10%-46.2M
Financing cash flow
Cash flow from continuing financing activities	125.03M	239.58%85.66M	-98.17%453K	3,000.00%31K	20,423.86%85.17M	0	-48.66%25.23M	2,949.57%24.79M	-100.00%1K	247.69%415K
Net common stock issuance	--125M	240.00%85M	-99.10%226K	--0	--84.77M	--0	-50.00%25M	--25M	--0	----
Proceeds from stock option exercised by employees	--198K	41.83%885K	136.46%454K	3,000.00%31K	-3.61%400K	--0	-36.71%624K	-76.38%192K	-98.99%1K	615.52%415K
Net other financing activities	---168K	43.11%-227K	----	----	----	----	78.46%-399K	----	----	----
Cash from discontinued financing activities
Financing cash flow	--125.03M	239.58%85.66M	-98.17%453K	3,000.00%31K	20,423.86%85.17M	--0	-48.66%25.23M	2,949.57%24.79M	-100.00%1K	247.69%415K
Net cash flow
Beginning cash position	-64.53%23.88M	-70.28%67.31M	-9.53%26.73M	110.25%104.17M	-47.43%59.46M	-70.28%67.31M	188.70%226.47M	-87.77%29.54M	-70.87%49.55M	8.54%113.11M
Current changes in cash	520.08%32.98M	72.71%-43.43M	-107.56%-2.85M	-287.15%-77.45M	170.35%44.72M	93.08%-7.85M	-207.52%-159.17M	349.76%37.76M	-127.97%-20M	-196.50%-63.56M
End cash Position	-4.38%56.85M	-64.53%23.88M	-64.53%23.88M	-9.53%26.73M	110.25%104.17M	-47.43%59.46M	-70.28%67.31M	-70.28%67.31M	-87.77%29.54M	-70.87%49.55M
Free cash flow	-45.21%-30.4M	-12.06%-86.54M	-55.78%-24.33M	-0.01%-19.72M	-16.85%-21.55M	10.68%-20.94M	-27.68%-77.22M	6.34%-15.62M	-59.36%-19.72M	-12.81%-18.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall